364 related articles for article (PubMed ID: 14962722)
21. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.
Bakkevold KE; Kambestad B
Eur J Surg Oncol; 1993 Apr; 19(2):147-61. PubMed ID: 7684003
[TBL] [Abstract][Full Text] [Related]
23. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
[TBL] [Abstract][Full Text] [Related]
24. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
[TBL] [Abstract][Full Text] [Related]
25. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D
Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
27. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
28. [Outcome of 268 patients with pancreatic carcinoma treated surgically].
Uravic M; Depolo A; Dobrilla-Dintinjana R; Petrosic N; Grbas H; Miletic D; Tomse Z; Kastelan Z
Zentralbl Chir; 2004 Apr; 129(2):125-9. PubMed ID: 15106045
[TBL] [Abstract][Full Text] [Related]
29. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
[TBL] [Abstract][Full Text] [Related]
30. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
[TBL] [Abstract][Full Text] [Related]
31. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Berger AC; Watson JC; Ross EA; Hoffman JP
Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
[TBL] [Abstract][Full Text] [Related]
32. Surgical treatment of pancreatic head carcinoma in elderly patients.
Brozzetti S; Mazzoni G; Miccini M; Puma F; De Angelis M; Cassini D; Bettelli E; Tocchi A; Cavallaro A
Arch Surg; 2006 Feb; 141(2):137-42. PubMed ID: 16490889
[TBL] [Abstract][Full Text] [Related]
33. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.
Delcore R; Rodriguez FJ; Forster J; Hermreck AS; Thomas JH
Am J Surg; 1996 Nov; 172(5):463-8; discussion 468-9. PubMed ID: 8942545
[TBL] [Abstract][Full Text] [Related]
34. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
35. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
36. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
37. [Results of resection for ductal adenocarcinoma of the pancreatic head].
Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
[TBL] [Abstract][Full Text] [Related]
38. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
39. Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients.
Kymionis GD; Konstadoulakis MM; Leandros E; Manouras A; Apostolou A; Alexiou D; Katsaragakis S; Androulakis G
J R Coll Surg Edinb; 1999 Aug; 44(4):231-5. PubMed ID: 10453145
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.
Millikan KW; Deziel DJ; Silverstein JC; Kanjo TM; Christein JD; Doolas A; Prinz RA
Am Surg; 1999 Jul; 65(7):618-23; discussion 623-4. PubMed ID: 10399969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
